Proto Labs (NYSE:PRLB) Earns Buy Rating from Benchmark

Proto Labs (NYSE:PRLB – Get Free Report)‘s stock had its “buy” rating restated by Benchmark in a report released on Wednesday, Benzinga reports. They currently have a $45.00 target price on the industrial products company’s stock. Benchmark’s price target points to a potential upside of 45.63% from the stock’s previous close. PRLB has been the […]

Related Keywords

United States ,Craig Hallum ,Charles Schwab Investment Management Inc ,Needham Company ,Brandywine Global Investment Management ,Partnership Wealth Management ,Proto Labs Inc ,Proto Labs Company Profile ,Caxton Associates ,Proto Labs ,Get Free Report ,Investment Management ,Wealth Management ,Global Investment Management ,Charles Schwab Investment Management ,Schwab Investment Management ,Proto Labs Daily ,